Related Experiment Video

Updated: Aug 3, 2026

Activation of Apoptosis by Cytoplasmic Microinjection of Cytochrome c
07:42

Activation of Apoptosis by Cytoplasmic Microinjection of Cytochrome c

Published on: June 29, 2011

BCL-2 stimulates Apoptin-induced apoptosis

A A Danen-Van Oorschot1, A J van der Eb, M H Noteborn

  • 1Department of Molecular Cell Biology, Leiden University Medical Center, The Netherlands.

Advances in Experimental Medicine and Biology
|September 29, 1999
PubMed

Insights

Apoptin, an avian virus protein, selectively triggers cancer cell death (apoptosis) independently of p53 and is enhanced by Bcl-2. It shows promise as a safe and effective anti-tumor therapy agent.

Area of Science:

  • Oncology
  • Molecular Biology
  • Virology

Background:

  • Apoptin, derived from an avian virus, induces apoptosis in tumor cells.
  • The proto-oncogene Bcl-2 typically inhibits apoptosis but unexpectedly accelerates Apoptin-induced cell death in tumor cells.
  • Apoptin's mechanism differs from p53-dependent apoptosis pathways.

Purpose of the Study:

  • To investigate Apoptin's mechanism of action in inducing apoptosis in tumor cells.
  • To explore the role of Bcl-2 in Apoptin-mediated apoptosis.
  • To evaluate Apoptin's therapeutic potential as an anti-tumor agent.

Main Methods:

  • Culturing various human tumorigenic and non-transformed cell lines.
  • Utilizing Apoptin and overexpressing Bcl-2 in cell models.
  • Conducting cellular localization studies (cytoplasmic vs. nuclear).
  • Assessing anti-tumor efficacy in animal models.

Main Results:

  • Apoptin induced p53-independent apoptosis in tumor cells (leukemia, lymphoma, EBV-transformed B cells).
  • Bcl-2 overexpression accelerated Apoptin-induced apoptosis in tumor cells, but not in normal cells.
  • Apoptin localized to the nucleus in tumor cells and the cytoplasm in normal cells.
  • Apoptin demonstrated safety and efficiency as an anti-tumor agent in animal models.

Conclusions:

  • Apoptin selectively targets tumor cells for apoptosis, independent of p53.
  • Bcl-2 specifically enhances Apoptin's pro-apoptotic function in tumor cells.
  • Apoptin's tumor-specific activity and safety profile suggest its potential as a novel anti-cancer therapeutic.

More Related Videos

Examining BCL-2 Family Function with Large Unilamellar Vesicles08:35

Examining BCL-2 Family Function with Large Unilamellar Vesicles

Published on: October 5, 2012

Applying an Inducible Expression System to Study Interference of Bacterial Virulence Factors with Intracellular Signaling08:51

Applying an Inducible Expression System to Study Interference of Bacterial Virulence Factors with Intracellular Signaling

Published on: June 25, 2015

Related Concept Videos

Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Phagocytosis of Apoptotic Cells01:17

Phagocytosis of Apoptotic Cells

Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or  immature dendritic cells. Non-professional phagocytes such as  epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes. 
Normal cells contain receptors that prevent them from being recognized by phagocytes.
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...